文献速递免疫规划

以肾致病性IBYZ株S1基因替换的H120重组传染性支气管炎冠状病毒保持致弱并诱导保护性免疫

Recombinant infectious bronchitis coronavirus H120 with the spike protein S1 gene of the nephropathogenic IBYZ strain remains attenuated but induces protective immunity.
PubMed 文献 · Vaccine · 2020-02-11

本研究基于H120疫苗株骨架,用反向遗传系统构建了以中国分离的QX样肾致病性ck/CH/IBYZ/2011株S1基因替换的重组株rH120-S1/YZ;该重组株在雏鸡中无死亡、无临床症状及肺肾病变,病毒载量在多数样本中较低,对QX样IBV攻击提供100%存活率且无病变,接种后14天血清IBV特异性抗体升高。

要点

  • 重组株rH120-S1/YZ在雏鸡中无死亡、无临床症状及肺肾病变,在多数样本中病毒载量较低。
  • rH120-S1/YZ接种鸡对QX样IBV攻击的存活率为100%,且无疾病症状或肉眼病变。
  • rH120-S1/YZ接种后14天血清中检测到IBV特异性抗体水平升高。

核心结论

  • 作者认为重组株rH120-S1/YZ可能是针对QX样传染性支气管炎病毒的有前景的候选疫苗。

研究设计与样本

  • 基于H120疫苗株骨架,用反向遗传系统构建以QX样肾致病性ck/CH/IBYZ/2011株S1基因替换的重组株rH120-S1/YZ。
  • 采用矮小鸡胚、生长动力学及胚内病毒滴定评估重组病毒的生物学特性。
  • 在雏鸡中评估rH120-S1/YZ的安全性,并与rH120及rIBYZ感染组比较。
  • 评估rH120-S1/YZ对QX样IBV攻击的保护效果,并与rH120疫苗接种组比较。

主要发现

  • 矮小鸡胚、生长动力学及胚内病毒滴定结果显示重组病毒的生物学特性保持不变。
  • 接种rH120-S1/YZ的雏鸡无死亡、无临床症状,肺部或肾脏无病变,与rH120感染组相似而与rIBYZ感染组不同。
  • rH120-S1/YZ接种鸡在多数类型样本中组织、泄殖腔拭子和口腔拭子的病毒载量较低。
  • 与rH120疫苗接种组相比,rH120-S1/YZ接种鸡对QX样IBV攻击的存活率为100%,且无疾病症状或肉眼病变,保护更好。
  • rH120-S1/YZ接种动物接种后14天血清中检测到IBV特异性抗体水平升高。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Infectious bronchitis (IB) is a highly infectious viral disease responsible for major economic losses in the poultry industry. A reverse genetic vaccine is a safe, rapid, and effective method of achieving IB prevention and control. In this study, we constructed the recombinant strain, rH120-S1/YZ, using a reverse genetic system, based on the backbone of the H120 vaccine strain, with the S1 gene replaced with that of the QX-like nephropathogenic strain, ck/CH/IBYZ/2011, isolated in China. The results of dwarf chicken embryos, growth kinetics, and viral titration in the embryos demonstrated that the biological characteristics of the recombinant virus remained unchanged. Like the rH120-infected group and in contrast to the rIBYZ-infected group, no mortality, clinical signs, or lesions were observed in the lungs or kidneys of young chickens inoculated with rH120-S1/YZ. The viral loads in various tissues, cloacal, and oral swabs was lower in most types of samples, indicating that the rH120-S1/YZ strain was highly safe in chicks. Compared to rH120 vaccination group, when the efficacy of this strain was evaluated against the QX-like IBV strain, better protection, with 100% survival rate and no disease symptom or gross lesion was observed in the chickens vaccinated with rH120-S1/YZ. Increased levels of IBV-specific antibodies were detected in the serum of the rH120-S1/YZ-vaccinated animals 14 days post-vaccination. Collectively, our results suggest that the recombinant strain, rH120-S1/YZ, may represent a promising vaccine candidate against QX-like IBVs.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Jiang Y, Cheng X, Zhao X, et al. Recombinant infectious bronchitis coronavirus H120 with the spike protein S1 gene of the nephropathogenic IBYZ strain remains attenuated but induces protective immunity. Vaccine. 2020. PMID: 32057575. doi:10.1016/j.vaccine.2020.01.001

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。